Cboe Global Markets, Inc. — Financial Data & Stock Exchanges. Scored on the same transparent model behind the daily rankings.
★
CBOE
Cboe Global Markets, Inc. · Financial Data & Stock Exchanges
FCF$2.7bB
Rev+15.1%B+
D/E0.29A-
P/E25.3xC
PEG2.90C
56.9Financial strength
$310.23$32.5B
1Y Target$312.43Analyst consensus · 14 analysts
5Y Target$457.43Compound horizon
10Y Target$678.56Long-dated conviction
FCF$2.7bTTM · 03/26B
FCF $2.7b — solid, comfortably covers operations and capital return · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev+15.1%FY YoYB+
Revenue +15.1% — above sector median, healthy trajectory · Computed from last two annual revenue figures (FY YoY).
D/E0.29A-
D/E 0.29 — less debt than most Financial Services peers (≈25th pctile)
P/E25.3xC
P/E 25.3 — expensive vs Financial Services peers (≈90th pctile)
PEG2.90C
PEG 2.90 — expensive relative to growth rate
Forward price target — the 1-year figure is the analyst consensus where the stock is covered; the 5- and 10-year figures compound our earnings estimate from there. The DCF below is a separate cross-check on intrinsic value (what it's worth today), not another target.
Financial strength · 56.9 / 100
Profitability0.95
Value (P/B)0.12
Income0.42
A peer-relative read for financials on profitability (ROE), valuation, and covered income — the quality-growth (FCF/ROIC) screen doesn't apply to balance-sheet businesses. Not comparable to the 0–100 quality-growth score shown on other stocks.
Entry · Margin of safety
52-week rangeMid-range
16% off the 12-month high
vs DCF fair value27% belowest. fair value ~$424
What the price assumes: free cash flow compounding at ~-2% a year for the next decade — vs the ~7% a year our model projects from current growth and analyst estimates.
Why now
Financial Data & Stock Exchanges · market cap $32.5b. 16% off the 52-week high of $371.18. Revenue growing +15%, comfortably above the S&P median. 14 sell-side analysts rate this a Hold with a mean 1-yr target of $312.43 (implying +1% upside).
Moat
Net margin 26% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 25% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
Horizon
1-3 yr $312.43 (14-analyst consensus) — fundamentals + valuation re-rating. 5 yr $457.43 at ~8% CAGR — compounding case rests on the competitive position widening. 10 yr $678.56 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Score history · CBOE
Not enough history yet — the model records CBOE's score after each daily run, and the chart appears once a few days have accumulated.
Position sizing · CBOE
$
%
%
Shares to buy
6
Position size
$1,861
3.7% of portfolio
Stop price
$232.67
25% below $310.23
$ at risk if stopped
$465.35
budget $500.00 · 1% of portfolio
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.
Cboe Global Markets, Inc. (CBOE): score, valuation & FAQ
Cboe Global Markets, Inc. (CBOE) is a Financial Data & Stock Exchanges company. As a bank, insurer or REIT it runs on a different financial model from the rest of the market, so Bull Rankings grades it on a sector-appropriate card — price-to-book, dividend yield, payout ratio and cash-flow coverage — rather than the 0–100 quality-growth score used elsewhere. The read below is a transparent screen, not a buy recommendation.
Its strongest graded signals are D/E (A-) and Rev (B+). On valuation, CBOE sits about 27% below our discounted-cash-flow fair value (a margin of safety) — the current price implies roughly -2% annual free-cash-flow growth over the next decade.
Is CBOE a good stock to buy?
Bull Rankings grades CBOE on a sector-appropriate card — price-to-book, dividend yield, payout and cash-flow coverage — rather than a single quality-growth score. That is driven by D/E (A-) and Rev (B+). A score is a quantitative screen of Cboe Global Markets, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.
How does Bull Rankings grade CBOE?
As a bank, insurer or REIT, CBOE isn't given a quality-growth score — signals like free cash flow, debt-to-equity and P/E don't translate cleanly to a balance-sheet business. Instead it's graded on a sector-appropriate card: price-to-book, dividend yield, payout ratio and operating-cash-flow coverage, where it rates strongest on D/E (A-) and Rev (B+).
Is CBOE overvalued or undervalued?
Based on $310.23, CBOE sits about 27% below our discounted-cash-flow fair value (a margin of safety) — the current price implies roughly -2% annual free-cash-flow growth over the next decade. It trades at a 25.3x× P/E (graded C). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.
What are the main risks of investing in CBOE?
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial adviser.
More Capital Markets & Asset Management stocks by score